NCT05423418: Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults |
|
|
| Recruiting | 1 | 60 | US | A244, B.63521, 50μg ALFQ, 100μg ALFQ, 200μg ALFQ | U.S. Army Medical Research and Development Command, US Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, National Institute of Allergy and Infectious Diseases (NIAID) | Human Immunodeficiency Virus (HIV), AIDS Virus | 10/23 | 10/28 | | |
NCT05423418: Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults |
|
|
| Recruiting | 1 | 60 | US | A244, B.63521, 50μg ALFQ, 100μg ALFQ, 200μg ALFQ | U.S. Army Medical Research and Development Command, US Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, National Institute of Allergy and Infectious Diseases (NIAID) | Human Immunodeficiency Virus (HIV), AIDS Virus | 10/23 | 10/28 | | |